170 related articles for article (PubMed ID: 32106685)
1. Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim.
Caulder CR; Kocherla CS; Qureshi ZP; Magagnoli J; Bookstaver PB
Ann Pharmacother; 2020 Sep; 54(9):852-857. PubMed ID: 32106685
[No Abstract] [Full Text] [Related]
2. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
Greenberg S; Reiser IW; Chou SY; Porush JG
Ann Intern Med; 1993 Aug; 119(4):291-5. PubMed ID: 8328737
[TBL] [Abstract][Full Text] [Related]
3. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
Greenberg S; Reiser IW; Chou SY
Am J Kidney Dis; 1993 Oct; 22(4):603-6. PubMed ID: 8213804
[TBL] [Abstract][Full Text] [Related]
4. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
Alappan R; Buller GK; Perazella MA
Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
[TBL] [Abstract][Full Text] [Related]
6. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
[TBL] [Abstract][Full Text] [Related]
7. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
Alappan R; Perazella MA; Buller GK
Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
9. Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study.
Lee KY; Huang CH; Tang HJ; Yang CJ; Ko WC; Chen YH; Lee YC; Hung CC
J Antimicrob Chemother; 2012 Nov; 67(11):2749-54. PubMed ID: 22821870
[TBL] [Abstract][Full Text] [Related]
10. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
Perazella MA; Mahnensmith RL
Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
[TBL] [Abstract][Full Text] [Related]
12. Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.
Hsu I; Wordell CJ
Ann Pharmacother; 1995 Apr; 29(4):427-9. PubMed ID: 7633023
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications.
Gentry CA; Nguyen AT
Ann Pharmacother; 2013 Dec; 47(12):1618-26. PubMed ID: 24259630
[TBL] [Abstract][Full Text] [Related]
14. Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men.
Witt JM; Koo JM; Danielson BD
Ann Pharmacother; 1996 Apr; 30(4):347-50. PubMed ID: 8729886
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors.
Coppens R; Yang J; Ghosh S; Gill J; Chambers C; Easaw JC
J Oncol Pharm Pract; 2019 Sep; 25(6):1366-1373. PubMed ID: 30124122
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose sulfamethoxazole/trimethoprim and glucocorticoid use on hyperkalemic event: A retrospective observational study.
Hirai T; Yamaga R; Ishikawa Y; Hanada K; Iwamoto T; Itoh T
J Infect Chemother; 2021 Nov; 27(11):1607-1613. PubMed ID: 34301486
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
19. Life-threatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia.
Du Plooy N; Rayner B
S Afr Med J; 2019 Jan; 109(2):89-90. PubMed ID: 30834857
[TBL] [Abstract][Full Text] [Related]
20. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
Nguyen AT; Gentry CA; Furrh RZ
Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
